Clinical Trial Update: The STAR™ Tumor Ablation Registry

View source ↗

Summary

A clinical trial registry update notes that Merit Medical's STAR Tumor Ablation Registry (NCT02419703) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Snippet

Sponsor: Merit Medical Systems, Inc. | Conditions: Metastatic Lesions in Vertebral Bodies | Status: TERMINATED